You are here

  • Home
  • Archive
  • Volume 10, Issue 2
  • Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer

 

Online download statistics by month:

Online download statistics by month: February 2022 to February 2026

AbstractFullPdf
Feb 202217801831531
Mar 2022617628153
Apr 202226426956
May 202230032476
Jun 2022563574106
Jul 202237237645
Aug 202225425832
Sep 202221922547
Oct 202221421683
Nov 202221221551
Dec 202216116134
Jan 202315415648
Feb 202315615838
Mar 202312913140
Apr 202312012241
May 202314214223
Jun 202310810827
Jul 202310210424
Aug 202311812224
Sep 2023778027
Oct 202327727851
Nov 202313013041
Dec 2023959620
Jan 2024727227
Feb 202410610630
Mar 202412412744
Apr 202410610635
May 202411211335
Jun 202411411340
Jul 2024969631
Aug 2024575877
Sep 2024101101160
Oct 20246969154
Nov 202410310438
Dec 20249910055
Jan 2025585825
Feb 2025808138
Mar 2025676734
Apr 2025899140
May 20259610340
Jun 2025373719
Jul 2025110
Sep 2025110
Feb 2026110
Total815383092540